Spencer Michels profiles the company that makes the HIV medicine, and the strides to make it affordable to those in the U.S. and poorer countries.
Johnson & Johnson executives were summoned to testify on Capitol Hill in the wake of a string of recalls that have left the company -- and the FDA -- under fire. Betty Ann Bowser updates the story.
A bill that would give the FDA regulatory authority over tobacco products and marketing moved closer to becoming law when the Senate approved the measure Thursday. Judy Woodruff gets two views on the legislation.
In a long-expected move, Time Warner announced plans to spin off AOL into a publicly traded company, ending their nine-year run together. A Washington Post reporter explains the company's move.
After 61 seasons, New York City's Amato Opera is staging its last performance on May 31 as its 88-year-old director, Tony Amato, retires. Ray Suarez reports.
The Senate neared approval Thursday of a bill to rein in credit card companies, which could mean new rules will be in place by early next year. Ray Suarez reports.
In other news, the House voted overwhelmingly to rein in credit card companies, and the Senate defeated a measure to give homeowners relief in federal bankruptcy court. In Iraq, British troops handed command of Basra to U.S. forces.
President Obama announced Monday new caps on executive pay for those firms receiving federal bailout aid. Analysts examine the new guidelines.
Question/Comment: Once companies securitize an asset and remove it from the books, are there provisions by which a company can obtain (purchase back) the asset from the special purpose entity? Since the market for collateralized debt obligations (…
Question/Comment: You used Harley Davidson as a success story in your "Rust Belt" series, but I understand that their workers were recently given unpaid leave. How do you reconcile this?Paul Solman: Because the workers still have good-paying jobs. Unpaid…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.